Day One Biopharmaceuticals Inc (DAWN) Key Ratios

Stock Card

$21.53

$0.00 (0.00%)

As on 24-Apr-2026 09:30EDT

Market cap

$2,225 Mln

Revenue (TTM)

$158 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	34.99	83.92	20.60	--	--
EBIT	-13.22	57.97	41.20	4.17	-198.26
Net Profit	-7.87	67.62	-12.38	7.58	-211.73
EPS	-7.87	70.68	4.51	15.26	-16.43
Book Value	--	--	-20.53	-5.59	47.57

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	Dec-25	Dec-24	Dec-23
EBIT-Margin	-123.21	-123.21	-80.76	-165.65	--
Net Margin	--	469,613.33	--	--	--
Return on equity	-33.64	-37.64	-22.74	-22.49	-55.68
Return on Capital	-33.53	-37.55	-22.61	-22.41	-55.58
Return on Assets	-30.57	-35.02	-19.68	-19.92	-52.11
Debt to Equity (x)	--	--	0.01	0.01	0.00

Profitability

View Detailed Peer Comparison

ROCE

-22.61

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-22.61	-22.41	-55.58	-43.04	-44.09
Peer Median	--	--	--	--	--

ROE

-22.74

Profit after tax / Average Net worth * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-22.74	-22.49	-55.68	-43.11	-44.18
Peer Median	--	--	--	--	--

ROA

-19.68

Profit after tax / Average Total assets * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-19.68	-19.92	-52.11	-41.38	-41.99
Peer Median	--	--	--	--	--

EBIT Margin

-80.76

Operating profit (EBIT) / Net Sales * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-80.76	-165.65	--	--	--
Peer Median	--	--	--	--	--

Net Margin

-67.85

Net profit / Total Income (Net sales plus other income) * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-67.85	-72.81	--	--	469,613.33
Peer Median	--	--	--	--	--

Growth

View Detailed Peer Comparison

Revenue Growth

0.21

Year on year growth in net sales

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	0.21	--	--	--	--
Peer Median	--	--	--	--	--

EBIT Growth

41.20

Year on year growth in operating profit (EBIT)

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	41.20	-5.44	-40.27	-101.96	-548.53
Peer Median	--	--	--	--	--

Net Profit Growth

-12.38

Year on year growth in profit after tax

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-12.38	49.45	-42.93	-87.64	-73.90
Peer Median	--	--	--	--	--

EPS Growth

-0.02

Year on year growth in earnings per share

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-0.02	0.57	-0.17	-0.06	-1.91
Peer Median	--	--	--	--	--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.01

Total debt / Net worth

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	0.01	0.01	0.00	0.00	0.00
Peer Median	--	--	--	--	--

Short term debt to equity ratio

0.00

(Short term borrowings / Net worth)

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	0.00	0.00	0.00	0.00	0.00
Peer Median	--	--	--	--	--

Current Ratio

8.02

Current Assets / Current Liabilities and Provisions

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	8.02	7.66	12.72	20.94	33.43
Peer Median	--	--	--	--	--

Quick Ratio

7.91

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	7.91	7.61	12.72	--	--
Peer Median	--	--	--	--	--

Interest Coverage

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	--	--	--	-30.95	-18,185.75
Peer Median	--	--	--	--	--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

16.90

Debtors outstanding / Net Sales * 100

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	16.90	10.58	--	--	--
Peer Median	--	--	--	--	--

Asset Turnover

0.29

Sales / Average Total Assets

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	0.29	0.27	--	--	--
Peer Median	--	--	--	--	--

Receivable days

46.89

Average Debtors / Sales * 365

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	46.89	19.32	--	--	--
Peer Median	--	--	--	--	--

Inventory Days

102.37

Average Inventory / Sales * 365

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	102.37	114.89	--	--	--
Peer Median	--	--	--	--	--

Payable days

74.23

Average Creditors / Cost of goods sold * 365

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	74.23	201.96	1,352.28	689.23	1,785.87
Peer Median	--	--	--	--	--

Cash Conversion Cycle

75.03

Receivable Days + Inventory Days - Payable Days

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	75.03	-67.75	--	--	--
Peer Median	--	--	--	--	--

Valuation

View Detailed Peer Comparison

Price / Earnings

-8.98

Current share price divided by earning per share in the last twelve months

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-8.98	-12.42	-6.17	-10.66	-8.84
Peer Median	--	--	--	--	--

Price / Book Value

2.18

Current share price divided by book value per share in the latest financial year

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	2.18	2.36	3.36	4.24	2.22
Peer Median	--	--	--	--	--

EV/EBITDA

-4.24

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Day One Biopharmaceuticals Inc (DAWN)	-4.24	-3.05	-3.88	-7.29	-4.67
Peer Median	--	--	--	--	--

Annual
Quarterly